Basis of virulence in a panton-valentine leukocidin-negative community-associated methicillin-resistant staphylococcus aureus strain

Journal of Infectious Diseases

Volumn 211, Issue 3, 2015, Pages 472-480

  Chen, Yan ^a,b   Yeh, Anthony J ^a   Cheung, Gordon Y C ^a   Villaruz, Amer E ^a   Tan, Vee Y ^a   Joo, Hwang Soo ^a   Chatterjee, Som S ^a,c   Yu, Yunsong ^b   Otto, Michael ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b ZHEJIANG UNIVERSITY   (China)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

alpha toxin; community associated infection; methicillin resistant Staphylococcus aureus; Panton Valentine leukocidin; phenol soluble modulins

Indexed keywords

AGR PROTEIN; ALPHA TOXIN; BACTERIAL TOXIN; PANTON VALENTINE LEUKOCIDIN; PHENOL SOLUBLE MODULIN; REGULATOR PROTEIN; UNCLASSIFIED DRUG; EXOTOXIN; HEMOLYSIN; LEUKOCIDIN; PANTON-VALENTINE LEUKOCIDIN; STAPHYLOCOCCAL ALPHA-TOXIN; VIRULENCE FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; CYTOLYSIS; ERYTHROCYTE; FEMALE; GENE LOCUS; GENETIC ANALYSIS; HUMAN; HUMAN CELL; IN VIVO STUDY; KOREA; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MOUSE; NEUTROPHIL; NONHUMAN; SKIN INFECTION; STRAIN DIFFERENCE; COMMUNITY ACQUIRED INFECTION; GENETIC ASSOCIATION; GENETICS; MICROBIOLOGY; SOUTH KOREA; VIRULENCE;

BACTERIAL TOXINS; COMMUNITY-ACQUIRED INFECTIONS; ERYTHROCYTES; EXOTOXINS; GENOME-WIDE ASSOCIATION STUDY; HEMOLYSIN PROTEINS; LEUKOCIDINS; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; NEUTROPHILS; REPUBLIC OF KOREA; VIRULENCE; VIRULENCE FACTORS;

EID: 84922576064     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/jiu462     Document Type: Article

References (45)

1. Klevens RM, Morrison MA, Nadle J, et al. Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA 2007; 298:1763-71.
2. Lowy FD. Antimicrobial resistance: the example of Staphylococcus aureus. J Clin Invest 2003; 111:1265-73.
3. DeLeo FR, Otto M, Kreiswirth BN, Chambers HF. Community-associated meticillin-resistant Staphylococcus aureus. Lancet 2010; 375:1557-68.
4. Moran GJ, Krishnadasan A, Gorwitz RJ, et al. Methicillin-resistant S. aureus infections among patients in the emergency department. N Engl J Med 2006; 355:666-74.
5. Chuang YY, Huang YC. Molecular epidemiology of community-associated meticillin-resistant Staphylococcus aureus in Asia. Lancet Infect Dis 2013; 13:698-708.
6. Rolo J, Miragaia M, Turlej-Rogacka A, et al. High genetic diversity among community-associated Staphylococcus aureus in Europe: results from a multicenter study. PLOS One 2012; 7:e34768.
7. Kock R, Becker K, Cookson B, et al. Methicillin-resistant Staphylococcus aureus (MRSA): burden of disease and control challenges in Europe. Euro Surveill 2010; 15:19688.
8. Chambers HF. Community-associated MRSA-resistance and virulence converge. N Engl J Med 2005; 352:1485-7.
9. Diep BA, Stone GG, Basuino L, et al. The arginine catabolic mobile element and staphylococcal chromosomal cassette mec linkage: convergence of virulence and resistance in the USA300 clone of methicillin-resistant Staphylococcus aureus. J Infect Dis 2008; 197:1523-30.
10. Lee SM, Ender M, Adhikari R, Smith JM, Berger-Bachi B, Cook GM. Fitness cost of staphylococcal cassette chromosome mec in methicil-lin-resistant Staphylococcus aureus by way of continuous culture. Antimicrob Agents Chemother 2007; 51:1497-9.
11. Otto M. Basis of virulence in community-associated methicillin-resistant Staphylococcus aureus. Annu Rev Microbiol 2010; 64:143-62.
12. Otto M. A MRSA-terious enemy among us: end of the PVL controversy? Nat Med 2011; 17:169-70.
13. Foster TJ. Immune evasion by staphylococci. Nat Rev Microbiol 2005; 3:948-58.
14. Voyich JM, Braughton KR, Sturdevant DE, et al. Insights into mechanisms used by Staphylococcus aureus to avoid destruction by human neutrophils. J Immunol 2005; 175:3907-19.
15. Tristan A, Bes M, Meugnier H, et al. Global distribution of Panton-Valentine leukocidin-positive methicillin-resistant Staphylococcus aureus, 2006. Emerg Infect Dis 2007; 13:594-600.
16. Spaan AN, Henry T, van Rooijen WJ, et al. The staphylococcal toxin Panton-Valentine Leukocidin targets human C5a receptors. Cell Host Microbe 2013; 13:584-94.
17. Wang R, Braughton KR, Kretschmer D, et al. Identification of novel cytolytic peptides as key virulence determinants for community-associated MRSA. Nat Med 2007; 13:1510-4.
18. Bubeck Wardenburg J, Bae T, Otto M, Deleo FR, Schneewind O. Poring over pores: alpha-hemolysin and Panton-Valentine leukocidin in Staph-ylococcus aureus pneumonia. Nat Med 2007; 13:1405-6.
19. Li M, Diep BA, Villaruz AE, et al. Evolution of virulence in epidemic community-associated methicillin-resistant Staphylococcus aureus. Proc Natl Acad Sci USA 2009; 106:5883-8.
20. Kobayashi SD, Malachowa N, Whitney AR, et al. Comparative analysis of USA300 virulence determinants in a rabbit model of skin and soft tissue infection. J Infect Dis 2011; 204:937-41.
21. Lipinska U, Hermans K, Meulemans L, et al. Panton-Valentine leuko-cidin does play a role in the early stage of Staphylococcus aureus skin infections: a rabbit model. PLOS One 2011; 6:e22864.
22. Otto M. Community-associated MRSA: what makes them special? Int J Med Microbiol 2013; 303:324-30.
23. Park SH, Park C, Yoo JH, et al. Emergence of community-associated methicillin-resistant Staphylococcus aureus strains as a cause of healthcare-associated bloodstream infections in Korea. Infect Control Hosp Epidemiol 2009; 30:146-55.
24. Bae T, Schneewind O. Allelic replacement in Staphylococcus aureus with inducible counter-selection. Plasmid 2006; 55:58-63.
25. Joo HS, Otto M. The isolation and analysis of phenol-soluble modu-lins of Staphylococcus epidermidis. Methods Mol Biol 2014; 1106: 93-100.
26. Chen Y, Chatterjee SS, Porcella SF, Yu YS, Otto M. Complete genome sequence of a Panton-Valentine leukocidin-negative community-associated methicillin-resistant Staphylococcus aureus strain of sequence type 72 from Korea. PLOS One 2013; 8:e72803.
27. Rigby KM, DeLeo FR. Neutrophils in innate host defense against Staph-ylococcus aureus infections. Semin Immunopathol 2012; 34:237-59.
28. Li M, Cheung GY, Hu J, et al. Comparative analysis of virulence and toxin expression of global community-associated methicillin-resistant Staphylococcus aureus strains. J Infect Dis 2010; 202:1866-76.
29. Queck SY, Jameson-Lee M, Villaruz AE, et al. RNAIII-independent target gene control by the agr quorum-sensing system: insight into the evolution of virulence regulation in Staphylococcus aureus. Mol Cell 2008; 32:150-8.
30. Cheung GY, Joo HS, Chatterjee SS, Otto M. Phenol-soluble modulins-critical determinants of staphylococcal virulence. FEMS Microbiol Rev 2013; 38:698-719.
31. Valeva A, Walev I, Pinkernell M, et al. Transmembrane beta-barrel of staphylococcal alpha-toxin forms in sensitive but not in resistant cells. Proc Natl Acad Sci USA 1997; 94:11607-11.
32. Gresham HD, Lowrance JH, Caver TE, Wilson BS, Cheung AL, Lind-berg FP. Survival of Staphylococcus aureus inside neutrophils contributes to infection. J Immunol 2000; 164:3713-22.
33. Surewaard B, de Haas C, Vervoort F, et al. Staphylococcal alpha-phenol soluble modulins contribute to neutrophil lysis after phagocytosis. Cell Microbiol 2013; 15:1427-37.
34. Cheung GY, Duong AC, Otto M. Direct and synergistic hemolysis caused by Staphylococcus phenol-soluble modulins: implications for diagnosis and pathogenesis. Microbes Infect 2012; 14:380-6.
35. Cooper LZ, Madoff MA, Weinstein L. Heat stability and species range of purified staphylococcal alpha-toxin. J Bacteriol 1966; 91:1686-92.
36. Kim ES, Song JS, Lee HJ, et al. A survey of community-associated meth-icillin-resistant Staphylococcus aureus in Korea. J Antimicrob Chemo-ther 2007; 60:1108-14.
37. Cheung GY, Wang R, Khan BA, Sturdevant DE, Otto M. Role of the accessory gene regulator agr in community-associated methicillin-resistant Staphylococcus aureus pathogenesis. Infect Immun 2011; 79:1927-35.
38. Recsei P, Kreiswirth B, O'Reilly M, Schlievert P, Gruss A, Novick RP. Regulation of exoprotein gene expression in Staphylococcus aureus by agr. Mol Gen Genet 1986; 202:58-61.
39. Soong G, Chun J, Parker D, Prince A. Staphylococcus aureus activation of caspase 1/calpain signaling mediates invasion through human kera-tinocytes. J Infect Dis 2012; 205:1571-9.
40. Berube BJ, Bubeck Wardenburg J. Staphylococcus aureus alpha-toxin: nearly a century of intrigue. Toxins 2013; 5:1140-66.
41. Inoshima I, Inoshima N, Wilke GA, et al. A Staphylococcus aureus pore-forming toxin subverts the activity of ADAM10 to cause lethal infection in mice. Nat Med 2011; 17:1310-4.
42. Kennedy AD, Bubeck Wardenburg J, Gardner DJ, et al. Targeting of alpha-hemolysin by active or passive immunization decreases severity of USA300 skin infection in a mouse model. J Infect Dis 2010; 202: 1050-8.
43. Hua L, Hilliard JJ, Shi Y, et al. Assessment of an anti-alpha-toxin monoclonal antibody for prevention and treatment of Staphylococcus aureus-induced pneumonia. Antimicrob Agents Chemother 2014; 58:1108-17.
44. Tkaczyk C, Hua L, Varkey R, et al. Identification of anti-alpha toxin monoclonal antibodies that reduce the severity of Staphylococcus aureus dermonecrosis and exhibit a correlation between affinity and potency. Clin Vaccine Immunol 2012; 19:377-85.
45. Bae IG, Tonthat GT, Stryjewski ME, et al. Presence of genes encoding the Panton-Valentine leukocidin exotoxin is not the primary determinant of outcome in patients with complicated skin and skin structure infections due to methicillin-resistant Staphylococcus aureus: results of a multinational trial. J Clin Microbiol 2009; 47:3952-7.